Analyst consensus rating
Kestra Medical Technologies Analyst Rating: none
KMTS is rated none by 7 analysts with a $30.00 target. As of 2026-09-01.
Direct answer
Kestra Medical Technologies's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $30.00.
Forecast evidence checked September 1, 2026.
Get free Kestra Medical Technologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.75
- Average price target
- $30.00
- High price target
- $32.00
- Low price target
- $28.00
- Low target gap
- +8.7%
- Target upside
- +16.5%
- High target gap
- +24.3%
- Target range width
- 15.5%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 1, 2026
- Valid through
- September 8, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Kestra Medical Technologies?
Kestra Medical Technologies has a verified none consensus. The same dataset has an average price target of $30.00.
How far are Kestra Medical Technologies's low and high targets from the recorded price?
The low target implies +8.7%, while the high target implies +24.3%.
How many analysts are included in Kestra Medical Technologies's consensus?
The verified consensus includes 7 analysts.
How is Kestra Medical Technologies's target upside or downside calculated?
The average target of $30.00 is divided by the recorded price of $25.75, then one is subtracted to produce +16.5%. This does not guarantee a future return.
When was Kestra Medical Technologies's analyst forecast verified?
The data was verified on 2026-09-01. The dataset is valid through 2026-09-08.